Unitary pricing bill pending in New Mexico; bills expected in 30 states.
PhRMA/NACDS DEBATE PRICING LAWS: NEW MEXICO IS NEXT FORUM, with a unitary pricing/equal access bill scheduled to be considered in the state Senate the week of March 6. New Mexico's House approved the measure by a 40-25 vote Feb. 24. A similar bill passed both state chambers handily last session but was vetoed by then-Gov. King (D). New Mexico is one of 30 states in which pricing legislation is actively being considered by the legislature or being drafted for introduction later in the session.
You may also be interested in...
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth